Axsome Therapeutics share price logo

Axsome Therapeutics

NASDAQ: AXSM

Mid Cap

$177.08

-2.17

(-1.21%)

as on

Axsome Therapeutics Stock Performance

as on October 6, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $175.76
    $179.55
    downward going graph

    0.75%

    Downside

    1.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $117.30
    $260.19
    downward going graph

    33.76%

    Downside

    46.93%

    Upside

    downward going graph

Axsome Therapeutics share price movements today

Previous Close
$179.25
Open
$179.55
Volume
616.1K
Market Cap
$9.4B
Day's Low - High
$175.76 - $179.55
52 Week Low - High
$117.30 - $260.19

Axsome Therapeutics Historical Returns

1 Month Return
-13.27 %
3 Month Return
-26.63 %
1 Year Return
+ 49 %
3 Year Return
+ 166.11 %
5 Year Return
+ 472.14 %

Axsome Therapeutics Stock Fundamentals & Key Indicators

Check Axsome Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.4B

EPS (TTM)

-3.75

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-47.8

Industry PE ratio

-11.70

PEG Ratio

-1.68

EBITDA

-179.8M

Revenue (TTM)

776.6M

Profit Margin

93.24%

Return On Equity TTM

-255.60%

Axsome Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Axsome Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$9.4B472.14%-47.8093.24%0.00%
StrongBuy$44.3B650.56%-23.320.00%0.00%
Neutral$75.9B-32.81%-23.81-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B32.91%17.5584.86%0.50%

Stock Returns calculator for Axsome Therapeutics Stock including INR - Dollar returns

The Axsome Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Axsome Therapeutics investment value today

Current value as on today

₹1,59,761

Returns

₹59,761

(+59.76%)

Returns from Axsome Therapeutics Stock

₹47,199 (+47.2%)

Dollar Impact

₹12,562 (+12.56%)

Analyst Recommendation on Axsome Therapeutics Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.3076923076923% of analysts recommend a 'BUY' rating for Axsome Therapeutics. Average target price of $284.63

Axsome Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Axsome Therapeutics.

What analysts predicted

37.79%UPSIDE

Target Price

$284.63

Current Price

$177.08

Analyzed by

13 Analysts

High

$380

Target

$284.63

Low

$247

Axsome Therapeutics target price $284.63, a slight upside of 37.79% compared to current price of $177.08. According to 13 analysts rating.

Indian Investors' Interest in Axsome Therapeutics Stock

Search interest for Axsome Therapeutics Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Axsome Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
74
87
104
118
121
150
170
195
191
218
Gross Profit
68
79
96
108
111
136
159
183
176
204
Operating Income
-67
-78
-62
-72
-56
-36
-46
-29
-63
-49
EBITDA
-65
-76
-60
-70
-54
-42
-44
-24
-61
-49
Interest Expense
1
1
1
2
2
1
1
1
1
1
Depreciation
1
1
2
2
2
2
1
2
2
-
Income Before Tax
-68
-79
-64
-74
-59
-48
-47
-28
-64
-51
Income Tax Expense
-
-
-
0
-
0
-
0
-
0
Net Income
-68
-79
-64
-74
-59
-47
-47
-28
-64
-51
Net Profit Margin
91.60%
90.76%
91.95%
91.15%
91.94%
91.04%
93.03%
93.71%
92.30%
93.79%

Axsome Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
50
270
385
638
Gross Profit
0
0
0
-
-
44
244
352
591
Operating Income
-27
-32
-67
-99
-124
-179
-231
-280
-169
EBITDA
-27
-32
-67
-100
-124
-175
-224
-272
-168
Interest Expense
1
1
1
2
5
7
6
6
6
Depreciation
0
0
0
0
0
4
6
7
9
Income Before Tax
-28
-30
-68
-102
-130
-187
-238
-287
-183
Income Tax Expense
-
-
-
-
-
-
0
0
0
Net Income
-28
-30
-68
-102
-130
-187
-239
-287
-183
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
89.61%
90.37%
91.37%
92.56%

Axsome Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-68
-79
-64
-74
-59
-47
-47
-28
-64
-51
Operating Cash Flow
-53
-30
-18
-26
-43
-32
1
-18
-20
-32
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-1
14
30
14
29
34
21
16
2
48
Change in Cash
-54
-15
11
-11
-14
2
22
-2
-17
14

Axsome Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-28
-30
-68
-102
-130
-187
-239
-287
-183
Operating Cash Flow
-26
-30
-46
-78
-108
-116
-145
-128
-93
Investing Cash Flow
0
0
0
0
0
-53
0
0
0
Financing Cash Flow
23
10
252
42
11
284
331
57
101
Change in Cash
-2
-20
205
-36
-97
114
185
-70
7

Global Institutional Holdings in Axsome Therapeutics

Check out the Institutions with significant holdings in Axsome Therapeutics.

Funds
Holdings
Vanguard
7.09%
VANGUARD INDEX FUNDS
6.53%
Delaware Group Equity Funds V
3.21%
iShares
3.06%
Fidelity Salem Street Trust
1.08%

Axsome Therapeutics News & Key Events

  • img

    Today's Timeline - 01 April

    Wed, 05:36 PM

    -

    Axsome Therapeutics acquires global rights to balipodect from Takeda for schizophrenia and Tourette syndrome development.

Insights on Axsome Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AXSM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -64.54M → -51.31M (in $), with an average increase of 25.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 191.20M → 218.37M (in $), with an average increase of 12.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 590.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AXSM stock has moved down by -4.9%

About Axsome Therapeutics

Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
OrganisationAxsome Therapeutics
HeadquartersOne World Trade Center, New York City, NY, 10007, US
IndustryBiotechnology
CEOHerriot Tabuteau

Key Management of Axsome Therapeutics

Name

Title

Mr. Mark L. Jacobson M.A.

Chief Operating Officer

Mr. Hunter Murdock Esq.

General Counsel & Secretary

Mr. Ari Maizel M.B.A.

Chief Commercial Officer

Darren Opland

Director of Corporate Communications

Dr. Herriot Tabuteau M.D.

Founder, Chairman, CEO & President

Mr. Nick Pizzie CPA, M.B.A.

Chief Financial Officer

FAQs

What is Axsome Therapeutics share price today?

Axsome Therapeutics share price today is $177.08 as on at the close of the market. Axsome Therapeutics share today touched a day high of $179.55 and a low of $175.76.

What is the 52 week high and 52 week low for Axsome Therapeutics share?

Axsome Therapeutics share touched a 52 week high of $260.19 on and a 52 week low of $117.30 on . Axsome Therapeutics stock price today i.e. is closed at $177.08,which is 31.94% down from its 52 week high and 50.96% up from its 52 week low.

What is Axsome Therapeutics's market capitalisation today?

Axsome Therapeutics market capitalisation is $0.01T as on .

How to invest in Axsome Therapeutics Stock (AXSM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Axsome Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Axsome Therapeutics Stock (AXSM) from India?

Indian investors can start investing in Axsome Therapeutics (AXSM) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in Axsome Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Axsome Therapeutics share’s latest price of $177.08 as on October 6, 2026 at 8:46 am IST, you will get 0.0565 shares of Axsome Therapeutics. Learn more about fractional shares .

What are the returns that Axsome Therapeutics has given to Indian investors in the last 5 years?

Axsome Therapeutics stock has given 472.14% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?